—Mkt Cap: —P/E: —
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringe…
Industry Peers
Health Care Technologyloading…
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value1.38B USD
Revenue (TTM)1.04B USD
Gross Profit676.80M USD
Net Income (TTM)95.40M USD
Revenue/Share17.74 USD
Last Price—
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees1.9K
CountryUS
SectorHealth Care
IndustryHealth Care Technology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)1.91
PEG—
EV/EBITDA4.17
EV/Revenue1.33
P/S0.19
P/B-0.31
EPS (TTM)1.89
EPS (Forward)1.74
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin62.64%
Oper. Margin19.34%
EBITDA Margin31.87%
Profit Margin8.83%
ROE-14.65%
ROA8.75%
Growth
Revenue Growth-14.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF191.70M USD
CapEx (TTM)9.30M USD
FCF Margin18.78%
FCF Yield—
Net Debt1.19B USD
Net Debt/EBITDA3.57
Balance Sheet
Debt/Equity-2.20
Current Ratio2.46
Quick Ratio1.34
Book Value/Sh-10.5530 USD
Cash/Share3.117 USD
Dividends
Fwd Div Rate0.4600 USD
Trail. Div Rate0.6000 USD
Div. Yield13.79%
5Y Avg Yield—
Payout Ratio31.75%
Ex-Div DateMay 28, 2026
Pay DateJun 15, 2026
Analyst Consensus
Rating3.3 (Hold)
Target (Mean)4.000 USD
Target Range3.000 USD – 5.000 USD
# Analysts2
Ownership
Shares Out.59.33M
Float58.36M
Insiders1.68%
Institutions106.22%
Short Interest
Short Ratio8.2d
Short % Float12.15%
Short % Out.10.20%
Shares Short6.05M
Short (prev mo.)5.28M
Technical
SMA 507.562 USD
SMA 20011.41 USD
Beta1.05
S&P 52W Chg28.31%
Avg Vol (30d)—
Avg Vol (10d)3.78M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—